Capricor Therapeutics disclosed insider trading filings with the SEC and was listed on the Nasdaq stock exchange.
7 reports, 2 independent
Updated Mon 00:00
Mostly repetition
Reached 2 outlets in its first 24 hours
- Reports
- 7
- Developments
- 2
- Repetition
- 71%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Capricor Therapeutics disclosed insider trading filings with the SEC and was listed on the Nasdaq stock exchange.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Insider trading disclosures made via SEC filings.1 source
Capricor Therapeutics filed insider trading disclosures and listed on Nasdaq.1 source
Keep exploring
The entities involved
Related events
- Astera Labs disclosed insider transactions via SEC filings while trading on the Nasdaq stock exchange.
- Insider trading disclosures filed with the SEC by IRADIMED CORPORATION on July 31, 2026.
- CNO Financial Group, Inc. filed insider trading disclosures with the SEC.
- Wix.com filed insider trading disclosures with the SEC on September 3, 2026.
- Insider trading disclosures for Synaptics were filed with the SEC, related to stock trades on NASDAQ.
Coverage
Newest first; wire copies grouped- themarketsdaily.com
- fool.comThis Capricor Insider Sold 24,000 Shares Before the Drop. With a New Catalyst on the Way, Is It Time to Buy? | The Motley Fool
- themarketsdaily.comStock Traders Purchase Large Volume of Call Options on Capricor Therapeutics (NASDAQ:CAPR)